Revelation Biosciences, Inc. beat EPS estimates 0% of the time across 3 reported quarters (0 beats, 3 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.83 | $-0.87 | -4.8% | Miss |
| Q12026 FY2026 | $-1.15 | $-2.71 | -135.7% | Miss |
| Q42025 FY2025 | $-1.41 | $-1.65 | -17.0% | Miss |
Back to REVB overview · REVB holders · REVB KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.